Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itay Lotan

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Neurology|March 19, 2026
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control StudyTasneem Kab, Keshet Pardo, Mark A Hellmann, et al.
Journal of the Neurological Sciences|January 24, 2020
Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitusItay Lotan, Robert W Charlson, Girish M Fatterpekar, et al.
Plos One|January 27, 2017
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort StudyHadas Stiebel-Kalish, Itay Lotan, Judith Brody, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 20, 2022
Elevated lumbar puncture opening pressure in aseptic meningitisMeital Ben-Dov, Avi Fellner, Ophir Keret, et al.
Journal of Neurology|June 26, 2018
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentationItay Lotan, Judith Brody, Mark Andrew Hellmann, et al.
The Israel Medical Association Journal : IMAJ|July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli CohortAviv Fineberg, Itay Lotan, Omer Bialer, et al.
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Immunology and Cell Biology|December 11, 2020
Alemtuzumab mediates the CD39<sup>+</sup> T-regulatory cell response via CD23<sup>+</sup> macrophagesLital Remez, Esther Ganelin-Cohen, Dina Safina, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
Multiple Sclerosis and Related Disorders|June 30, 2020
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosisItay Lotan, Esther Ganelin-Cohen, Evgeny Tartakovsky, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Neurology|March 19, 2026
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control StudyTasneem Kab, Keshet Pardo, Mark A Hellmann, et al.
Journal of the Neurological Sciences|January 24, 2020
Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitusItay Lotan, Robert W Charlson, Girish M Fatterpekar, et al.
Plos One|January 27, 2017
Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort StudyHadas Stiebel-Kalish, Itay Lotan, Judith Brody, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 20, 2022
Elevated lumbar puncture opening pressure in aseptic meningitisMeital Ben-Dov, Avi Fellner, Ophir Keret, et al.
Journal of Neurology|June 26, 2018
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentationItay Lotan, Judith Brody, Mark Andrew Hellmann, et al.
The Israel Medical Association Journal : IMAJ|July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli CohortAviv Fineberg, Itay Lotan, Omer Bialer, et al.
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Immunology and Cell Biology|December 11, 2020
Alemtuzumab mediates the CD39<sup>+</sup> T-regulatory cell response via CD23<sup>+</sup> macrophagesLital Remez, Esther Ganelin-Cohen, Dina Safina, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
Multiple Sclerosis and Related Disorders|June 30, 2020
Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosisItay Lotan, Esther Ganelin-Cohen, Evgeny Tartakovsky, et al.
Pageof 8